Overall survival of patients with BRAF-mutant metastatic colorectal cancer treated with encorafenib-cetuximab in a real-world nationwide study in the Netherlands.

Autor: van Nassau, Sietske C.M.W., Zwart, Koen, van der Baan, Frederieke, Koopman, Miriam, van Gestel, Anna J., Snaebjornsson, Petur, Vink, Geraldine R., Roodhart, Jeanine
Zdroj: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p3589-3589, 1p
Databáze: Supplemental Index